The effects of a novel NSAID on chronic neuroinflammation are age dependent

Neurobiology of Aging

Volumn 20, Issue 3, 1999, Pages 305-313

  Hauss Wegrzyniak, Beatrice ^a   Vraniak, Peter ^a   Wenk, Gary L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Aging; Alzheimer's disease; Animal models; Microglia; Neuroinflammation; Nonsteroidal anti inflammatory drugs; Rats; Spatial memory; Water maze

Indexed keywords

FLURBIPROFEN; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC INFLAMMATION; HISTOLOGY; LEARNING; MALE; MICROGLIA; NEURITIS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

EID: 0033133362     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(99)00028-7     Document Type: Article

References (63)

1. Andersen K., Launer L.J., Ott A., Hoes A.W., Breteler M.M.B., Hoffman A. Do nonsteroidal anti-inflammatory drugs decrease the risk of Alzheimer's disease? Neurology. 45:1995;1441-1445.
2. Berg L., Morris J.C. Aging and dementia. Pearlman A.L., Collins R.C. Neurobiology of disease. 1990;299-322 Oxford University Press, New York.
3. Breitner J.C.S., Gau B.A., Welsh K.A., et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease. Neurology. 44:1994;227-232.
4. Cacabelos R., Alvarez X.A., Fernandez-Novoa L., et al. Brain IL-1 beta in Alzheimer's disease and vascular dementia. Meth Find Exp Clin Pharmacol. 16:1994;141-145.
5. Cao C., Matsumura K., Ozaki M., Watanabe Y. Lipopolysaccharide injected into the cerebral ventricle evokes fever through induction of cyclooxygenase-2 in brain endothelial cells. J Neurosci. 19:1999;716-725.
6. Cotman C.W., Tenner A.J., Cummings B.J. β-Amyloid converts an acute phase injury response to chronic injury responses. Neurobiol Aging. 17:1996;723-731.
7. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.-H.C., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1993;93-101.
8. DiPatre P.L., Gelman B.B. Microglial cell activation in aging and Alzheimer disease - partial linkage with neurofibrillary tangle burden in the hippocampus. J Neuropathol Exp Neurol. 56:1997;143-149.
9. Eikelenboom P., Zhan S.S., van Gool A., Allsop D. Inflammatory mechanisms in Alzheimer's disease. TIPS. 15:1994;447-450.
10. Frederickson R.C.A., Burden K.R. New opportunities in AD research - roles of immunoinflammatory response and glia. Alzheimer Dis Assoc Disord. 8:1994;159-166.
11. Geula C. Abnormalities of neuronal circuitry in Alzheimer's disease hippocampus and cortical cholinergic innervation . Neurology. 51:1998;S18-S29.
12. Graves A.B., White E., Koepsell T.D., et al. The association between head trauma and Alzheimer's disease. Am J Epidemiol. 131:1990;491-501.
13. Griffin W.S.T., Stanley L.C., Ling C., et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down Syndrome and Alzheimer's disease. Proc Natl Acad Sci USA. 86:1989;7611-7615.
14. Griffin W.S.T., Sheng J.G., Roberts G.W., Mrak R.E. IL-1 expression in different plaque types in Alzheimer's disease significance in plaque evolution . J Neuropathol Exp Neurol. 54:1995;276-281.
15. Griffin W.S.T., Sheng J.G., McKenzie J.E., et al. Life-long overexpression of S100β in Down's syndrome implications for Alzheimer pathogenesis . Neurobiol Aging. 19:1998;401-405.
16. Gu Z.Z., Yu J.A., Perez Polo J.R. Responses in the aged rat brain after total immunolesion. J Neurosci Res. 54:1998;7-16.
17. Hanisch U.-K., Neuhaus J., Rowe W., et al. Neurotoxic consequences of central long-term administration of IL-2 in rats. Neuroscience. 79:1997;799-818.
18. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J.D., Wenk G.L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 780:1998;294-303.
19. Hauss-Wegrzyniak B., Lukovic L., Bigaud M., Stoeckel M.E. Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide an immunohistochemical study . Brain Res. 794:1998;211-224.
20. Hauss-Wegrzyniak B., Willard L.B., Del Soldato P., Pepeu G., Wenk G.L. Peripheral administration of novel anti-inflammatories can attenuate the effect of chronic inflammation within the CNS. Brain Res. 815:1998;36-43.
21. Hof P.R. Morphology and neurochemical characteristics of the vulnerable neurons in brain aging and Alzheimer's disease. Eur Neurol. 37:1997;71-81.
22. Kalehua A.N., Mangiarotti F., Hengemihle J., Speer D.L., Ingram D.K., DeSimoni M.G. Glia response to ICV lipopolysaccharide injections in mice of different ages. Soc Neurosci Abstr. 22:1996;488.
23. Kitagawa H., Takeda F., Kohei H. Effect of endothelium-derived relaxing factor on the gastric lesion induced by HCl in rats. J Pharmacol Exp Therap. 253:1990;1133-1137.
24. Li G., Shen Y.C., Chen C.H., Zhau Y.W., Silverman J.M. A case control study of Alzheimer's disease in China. Neurology. 42:1992;1481-1482.
25. Lindner M.D., Schallert T. Aging and atropine effects on spatial navigation in the Morris water task. Behav Neurosci. 102:1988;621-634.
26. Lucca U., Tettamanti M., Forloni G., Spagnoli A. Nonsteroidal anti-inflammatory drug use in Alzheimer's disease. Biol Psychiatry. 36:1994;854-856.
27. Mackenzie I.R.A., Munoz D.G. Nonsteroidal anti-inflammatory drugs and Alzheimer-type pathology in aging. Neurology. 50:1998;986-990.
28. MacNaughton W.K., Cirino G., Wallace J.L. Endothelium-derived releasing factor (nitric oxide) has protective actions in the stomach. Life Sci. 45:1989;1869-1876.
29. Mann D.M.A. Pathological correlates of dementia in Alzheimer's disease. Neurobiol Aging. 15:1994;357-360.
30. Matsumura K., Cao C., Ozaki M., Morii H., Nakadate K., Watanabe Y. Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever; light and electron microscopic immunocytochemical studies. J Neurosci. 18:1998;6279-6289.
31. McGeer P.L., Itagaki S., Tago H., McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for histocompatibility glycoprotein HLA-DR. Neurosci Lett. 79:1987;195-200.
32. McGeer P.L., Akiyama H., Itagaki S., McGeer E.G. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett. 107:1989;341-346.
33. McGeer P.L., McGeer E.G., Rogers J., Sibley J. Anti-inflammatory drugs and Alzheimer's disease. Lancet. 335:1990;1037.
34. McGeer P.L., Harada N., Kimura H., McGeer E.G., Schulzer M. Prevalence of dementia amongst elderly Japanese with leprosy apparent effect of chronic drug therapy . Dementia. 3:1992;146-149.
35. McGeer P.L., McGeer E.G. The inflammatory response system of brain implication for therapy of Alzheimer's disease and other neurodegenerative disease . Brain Res Rev. 21:1995;195-218.
36. Morris R.G.M., Garrud P., Rawlins J.N.P., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 297:1982;681-683.
37. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Meth. 11:1984;46-60.
38. Morrison J.H., Hof P.R. Life and death of neurons in aging brain. Science. 278:1997;412-419.
39. Mrak R.E., Sheng J.G., Griffin W.S.T. Glial cytokines in Alzheimer's disease review and pathogenic implications . Hum Pathol. 26:1995;816-823.
40. Mrak R.E., Sheng J.G., Griffin W.S.T. Correlation of astrocytic S100β expression with dystrophic neurits in Amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol. 55:1996;273-279.
41. Ogura K., Ogawa M., Yoshida M. Effects of ageing on microglia in the normal rat brain immunohistochemical observations . NeuroReport. 5:1994;1224-1226.
42. Pasinetti G.M. Cyclooxygenase and inflammation in Alzheimer's disease experimental approaches and clinical interventions . J Neurosci Res. 54:1998;1-6.
43. Rich J.B., Rasmusson D.X., Folstein M.F., Carson K., Kawas C., Brandt J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology. 45:1995;51-55.
44. Robertson M.R., Harrell L.E. Cholinergic activity and amyloid precursor protein metabolism. Brain Res Rev. 25:1997;50-69.
45. Rogers J., Cooper N., Webster S., et al. Complement activation by b-amyloid in Alzheimer's disease. Proc Natl Acad Sci USA. 89:1992;10016-10020.
46. Rogers J., Kirby L.C., Hempelman S.R., et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology. 43:1993;1609-1611.
47. Rogers J., Webster S., Lue L.-H., et al. Inflammation, and Alzheimer's disease pathogenesis. Neurobiol Aging. 17:1996;681-686.
48. Rogers J., Griffin S.T. Inflammatory mechanisms of Alzheimer's disease. Basic research, clinical studies, and future directions. Wood P.L. Neuroinflammation mechanisms and management . 1998;177-193 Humana Press, Totowa, NJ.
49. Rozovsky I., Finch C.E., Morgan T.E. Age-related activation of microglia and astrocytes - in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation. Neurobiol Aging. 19:1998;97-103.
50. Santini G., Sciulli M.G., Padovano R., et al. Effects of flurbiprofen and flurbinitroxybutylester on prostaglandin endoperoxidase synthases. Eur J Pharmacol. 316:1996;65-72.
51. Shalit F., Sredni B., Stern L., Kott E., Huberman M. Elevated IL-6 secretion levels by mononuclear cells of Alzheimer's patients. Neurosci Lett. 174:1994;130-132.
52. Sharif S.F., Hariri R.J., Chang V.A., Barie P.S., Wang R.S., Ghajar J.B. Human astrocyte production of TNF-alpha, IL-1 beta and IL-6 following exposure to lipopolysaccharide endotoxin. Neurol Res. 15:1993;109-112.
53. Sheffield L.G., Berman N.E.J. Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol Aging. 19:1998;47-55.
54. Sheng J.G., Mrak R.E., Griffin W.S.T. Microglial IL-1 alpha expression in brain regions in Alzheimer's disease correlation with neuritic plaque distribution . Neuropathol Appl Neurobiol. 21:1995;290-301.
55. Sheng J.G., Griffin W.S.T., Royston M.C., Mrak R.E. Distribution of IL-1 immunoreactive microglia in cerebral cortical layers implications for neuritic plaque formation in Alzheimer's disease . Neuropathol Appl Neurobiol. 24:1998;278-283.
56. Sheng J.G., Mrak R.E., Griffin W.S.T. Enlarged and phagocytic, but not primed, IL-1-alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol. 95:1998;229-234.
57. Stewart W.F., Kawas C., Corrada M., Metter J. Risk of Alzheimer's disease and duration of NSAID use. Neurology. 48:1997;626-632.
58. Styren S.D., Civin W.H., Rogers J. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer disease brain. Exp Neurol. 110:1990;93-104.
59. Tooyama I., Kimura H., Akiyama H., McGeer P.L. Reactive microglia express class I and II major histocompatibility complex antigens in Alzheimer's disease. Brain Res. 523:1990;273-280.
60. Van Eldik L.J., Griffin W.S.T. S100β expression in Alzheimer's disease relation to neuropathology in brain regions . Biochim Biophys Acta. 1223:1994;398-403.
61. Wallace J.L., Reuter B., Cicala C., McKnight W., Grisham M.B., Cirino G. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology. 107:1994;173-179.
62. Weldon D.T., Maggio J.E., Manthy P.W. New insights into the neuropathology and cell biology of Alzheimer's disease. Geriatrics. 52:1997;S13-S16.
63. Wenk G.L., Hauss-Wegrzyniak B., Willard L.B. Pathological and biochemical studies of chronic neuroinflammation may lead to therapies for Alzheimer's disease. Patterson P., Kordon K., Christen Y. Neuro-Immune Interactions Proceedings of IPSEN Foundation Meeting . 2000;73-77 Springer-Verlag, Paris.